IRIXMEDIUM SIGNALFINANCIAL10-K

IRIX demonstrated meaningful improvement in profitability metrics with substantially reduced losses and improved operating performance in fiscal 2025.

The company cut its net losses in half while significantly improving operating income, suggesting better cost management and operational efficiency. However, the business remains unprofitable and continues to face headwinds from extended customer purchase decision cycles in the current macroeconomic environment.

Comparing 2026-04-02 vs 2025-03-27View on EDGAR →
FINANCIAL ANALYSIS

IRIX showed notable financial improvement across key profitability metrics, with operating income losses substantially reduced and cash flow from operations improving meaningfully. The company also reduced R&D expenses by 33% and lowered inventory levels by 27%, while maintaining higher accounts receivable levels. Overall, the financial picture signals better cost discipline and operational management, though the company continues to burn cash and remains in a loss-making position.

FINANCIAL STATEMENT CHANGES
Share Buybacks
Cash Flow
-96.2%
$1.6M$59K

Buyback activity reduced 96.2% — capital being redeployed elsewhere or cash conservation underway.

Operating Cash Flow
Cash Flow
+71%
-$7.3M-$2.1M

Operating cash flow surged 71% — exceptional cash generation, highest quality earnings signal.

Operating Income
P&L
+69%
-$8.3M-$2.6M

Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.

Net Income
P&L
+50.2%
-$8.9M-$4.4M

Net income grew 50.2% — bottom-line growth signals improving overall business health.

R&D Expense
P&L
-32.7%
$5.4M$3.7M

R&D spending cut 32.7% — could signal cost discipline or concerning reduction in innovation investment.

Accounts Receivable
Balance Sheet
+27.9%
$6.0M$7.6M

Receivables grew 27.9% — monitor days sales outstanding for collection efficiency.

Inventory
Balance Sheet
-27.2%
$10.8M$7.9M

Inventory reduced 27.2% — lean inventory management or demand outpacing supply.

Current Liabilities
Balance Sheet
-20.2%
$16.6M$13.2M

Current liabilities reduced — improved short-term financial position and working capital health.

Total Debt
Balance Sheet
-19.9%
$1.2M$1.0M

Debt reduced 19.9% — deleveraging strengthens balance sheet and reduces financial risk.

Total Liabilities
Balance Sheet
-10.4%
$27.0M$24.2M

Liabilities reduced 10.4% — deleveraging improves balance sheet strength and financial flexibility.

LANGUAGE CHANGES
NEW — 2026-04-02
PRIOR — 2025-03-27
ADDED
As of March 27, 2026, Registrant ha d 17,307,401 shares of common stock outstanding.
In the fiscal year ended January 3, 2026 ( fiscal year 2025 ) and the fiscal year ended December 28, 2024 ( fiscal year 2024 ), our products were sold in the United States and Germany predominantly through a direct sales force and internationally (aside from Germany, Italy, UK (Glaucoma), India, and other smaller markets) primarily through Topcon Corporation ( Topcon ) and other independent distributors.
Total revenues in fiscal years 2025 and 2024 were $52.7 million and $48.7 million, respectively.
We generated net losses of $4.4 million and $8.9 million in fiscal years 2025 and 2024, respectively.
As a result, we have seen customers extend purchase decision cycles that have impacted and may continue to impact our operations.
+7 more — sign up free →
REMOVED
As of March 21, 2025, Registrant had 16,789,027 shares of common stock outstanding.
In 2024 and 2023, our products were sold in the United States and Germany predominantly through a direct sales force and internationally (aside from Germany, Italy, UK (Glaucoma), India, and other smaller markets) primarily through Topcon Corporation ( Topcon ) and other independent distributors.
Total revenues in 2024 and 2023 were $48.7 million and $51.9 million, respectively.
We generated net losses of $8.9 million and $9.6 million in 2024 and 2023, respectively.
Impact of Macroeconomic Conditions to our Business Current macroeconomic conditions exhibit challenges that can affect capital equipment purchasing demand and timing, including recessionary fears, inflation concerns, changing interest rates, tariffs, trade wars, unexpected changes in taxes or policies, as well as other geopolitical developments and uncertainty, have impacted and may continue to impact business spending and the economy as a whole.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →